389 related articles for article (PubMed ID: 20513524)
1. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
[TBL] [Abstract][Full Text] [Related]
2. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
3. Sputum eosinophilia in Churg-Strauss syndrome.
Meziane H; Maakel ML; Vachier I; Bousquet J; Chanez P
Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
[TBL] [Abstract][Full Text] [Related]
4. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
5. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
6. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and treatment of Churg-Strauss syndrome.
Baldini C; Talarico R; Della Rossa A; Bombardieri S
Rheum Dis Clin North Am; 2010 Aug; 36(3):527-43. PubMed ID: 20688248
[TBL] [Abstract][Full Text] [Related]
8. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma.
Busse WW; Ring J; Huss-Marp J; Kahn JE
J Allergy Clin Immunol; 2010 Apr; 125(4):803-13. PubMed ID: 20371394
[TBL] [Abstract][Full Text] [Related]
9. [The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].
Szczeklik W; Sokołowska BM; Mastalerz L; Górka J; Pacułt K; Soja J; Musiał J
Przegl Lek; 2010; 67(7):439-42. PubMed ID: 21387750
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
11. Churg Strauss syndrome after introducing oral steroid to inhaler: a report of three cases.
Fallah-Tafti S; Mansouri D; Masjedi MR; Marashian M; Faridian D
Iran J Allergy Asthma Immunol; 2006 Jun; 5(2):89-94. PubMed ID: 17237583
[TBL] [Abstract][Full Text] [Related]
12. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
13. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
[TBL] [Abstract][Full Text] [Related]
14. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.
Cottin V; Khouatra C; Dubost R; Glérant JC; Cordier JF
Allergy; 2009 Apr; 64(4):589-95. PubMed ID: 19154547
[TBL] [Abstract][Full Text] [Related]
15. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature.
Agard C; Rendu E; Leguern V; Ponge T; Masseau A; Barrier JH; Trochu JN; Hamidou MA; Guillevin L
Semin Arthritis Rheum; 2007 Jun; 36(6):386-91. PubMed ID: 17303217
[TBL] [Abstract][Full Text] [Related]
16. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
17. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome.
Kawakami T; Soma Y; Kawasaki K; Kawase A; Mizoguchi M
Arch Dermatol; 2005 Jul; 141(7):873-8. PubMed ID: 16027304
[TBL] [Abstract][Full Text] [Related]
18. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
19. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
20. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients].
Lou J; Xu WB
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):524-8. PubMed ID: 19567070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
